The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review

by Eirini Palaka, Susan Grandy, Heleen van Haalen, Phil McEwan, Oliver Darlington
Published 2020-01-01

Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.

by Kasper Adelborg, Sia Kromann Nicolaisen, Pål Hasvold, Eirini Palaka, Lars Pedersen, Reimar Wernich Thomsen
Published 2019-01-01

Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: Cross sectional analysis of real-world data

by Heleen van Haalen, James Sloand, Rebecca Moon, Eirini Palaka, Gary Milligan, Alaster Allum, James Jackson
Published 2020-09-01

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

by Marc Evans, Eirini Palaka, Hans Furuland, Hayley Bennett, Cecilia Linde, Lei Qin, Phil McEwan, Ameet Bakhai
Published 2019-01-01

A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma

by Dawn Odom, Deirdre Mladsi, Molly Purser, James A. Kaye, Eirini Palaka, Alina Charter, Jo Annah Jensen, Dalila Sellami
Published 2017-01-01

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink

by Hans Furuland, Phil McEwan, Marc Evans, Cecilia Linde, Daniel Ayoubkhani, Ameet Bakhai, Eirini Palaka, Hayley Bennett, Lei Qin
Published 2018-08-01